Blog Viewer

Regional Meeting in Dubai

By Currents Editor posted 01-17-2019 14:15

  

Yasser_B__Abulhasan.jpgDr_Hussain_27233_.jpgBy Yasser B. Abulhasan, Chairman, Neurocritical Care-MENA Chapter of IPACCMS, and Hussain N. Al Rahma, President, IPACCMS

It is a great pleasure to welcome you all to the first Regional Neurocritical Care Meeting in the Middle East and Africa, which was developed in partnership between the International Pan Arab Critical Care Medicine Society and the Neurocritical Care Society as part of the 15th Emirates Critical Care Conference (ECCC) on April 4-6, 2019, in Dubai, United Arab Emirates (www.eccc-dubai.com).

There will be a highlighted full day neurocritical care track (April 5) presenting topics and practice updates that will cover ischemic stroke, intracranial hemorrhage, traumatic brain injury management, challenges in diagnosis, general critical care and prognostication of the neurological injured patient. Courses and workshops will include an Emergency Neurological Life Support course (April 4), a Determination of Brain Death workshop (April 6) and an Introduction to Transcranial Doppler workshop (April 6). Original accepted abstracts relevant to basic, translational and clinical research in neurocritical care will qualify for publication in the Neurocritical Care journal. Additionally, a newly developed award will be presented at the meeting for the outstanding scientific abstract presented at the conference. Online abstract submission is currently open at the conferences website.

To facilitate a stronger international neurocritical care presence, please join us in Dubai, April 4-6, 2019, to mark the achievement of this milestone, promote multidisciplinary quality patient care, discuss research ideas and develop professional collaborations.

#NCSRoundup #International #Dubai #December2018 #YasserBAbulhasan #HussainN.AlRahma

​​​​​​
FURTHER READING
By: (from left to right) Sydney Moseley, MD, Hussein Alshammari, MD, Scott Woolf, DO, Fawaz Al-Mufti, MD 1 1 Department of Neurology and Neurosurgery, Westchester Medical Center at New York Medical College The authors have no actual or potential conflict of interest in relation to ...
 By:  Danielle Marut, PharmD (left), Jessica Traeger, PharmD, BCCCP (right) The use of oral factor Xa inhibitors, including rivaroxaban and apixaban, has increased over the last several years. Historically, strategies for the treatment of bleeding patients taking these agents included supportive ...
By Bnar Shawki, MD, MBChB, F.I.C.M.S, FIPP, Head of Anesthesia Department in RozhHalat Emergency Hospital, Erbil, Iraq (left); Firas Abdulmajeed, MBChB, Assistant Professor of Critical Care Medicine and Neurology, University of Pittsburgh, USA (right) The population of Iraq is 37,203,000, according ...